Antonia Luna-Flores
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antonia Luna-Flores has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- J. Raul Olmos-Zuniga
Experimental Lung Transplant Laboratory, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosio Villegas, Mexico City, Mexico.
2 shared publications - Mariana Silva-Martínez
Experimental Lung Transplant Unit of the Department of Experimental Surgery, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico
2 shared publications - Miguel Gaxiola-Gaxiola
Morphology Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico
2 shared publications - Rogelio Jasso-Victoria
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas Ciudad de México México
2 shared publications - Andrea Nachón-Acosta
Experimental Lung Transplant Unit of the Department of Experimental Surgery, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico
1 shared publication - Edgar Zenteno
Universidad Nacional Autónoma de México
1 shared publication
Latest Publications
- 1 June 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (7) , 1551-1561
Clinical, Histological, and Profibrotic Extracellular Matrix Protein Changes in a Model of Tracheal Stenosis Induced by Cervical Tracheal Autotransplantation
Tracheal stenosis (TS) is a complication of prolonged intubation, tracheotomy, and tracheal surgery that compromises the vascular supply. Animal models are essential for studying its pathophysiology and the effect of interventions. To establish a TS model in rats secondary to tracheal autotransplantation with a graft submerged in bleomycin (Atx-Bleo). Additionally, to evaluate the clinical and histological changes, as well as the expression of newly formed collagen (NFC), isoforms of transforming growth factor beta (TGFβ), fibronectin (FN), elastin (ELN), integrin β1 (ITGβ1), and matrix metalloproteinase 1 (MMP1) in TS. Twenty Wistar rats were divided into three groups: group I (n = 20) control; group II (n = 10) end-to-end anastomosis of the trachea (tracheoplasty); and group III (n = 10) Atx-Bleo. The animals were evaluated clinically, tomographically, macroscopically, morphometrically, and microscopically. NFC deposition, and the expression of profibrotic and antifibrotic proteins were evaluated in tracheal scars. All animals survived the surgical procedure and the study period. Compared with the other study groups, the Atx-Bleo group developed TS and fibrosis, exhibited higher expression of NFC, TGFβ1, TGFβ2, FN, ELN, and ITGβ1, and mild expression of TGFβ3 and MMP1 (p < 0.005; analysis of variance, Dunnett and Tukey tests). Atx-Bleo in TS model rats produces tomographic and histological changes, and induces the upregulation of profibrotic proteins (TGFβ1, TGFβ2, collagen, FN, ELN, ITGβ1) and downregulation of antifibrotic proteins (TGFβ3, MMP1). Therefore, this model may be used to test new pharmacological treatments for reversing or preventing TS, and conduct basic studies regarding its pathophysiology.
- 1 June 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (7) , 1551-1561
Clinical, Histological, and Profibrotic Extracellular Matrix Protein Changes in a Model of Tracheal Stenosis Induced by Cervical Tracheal Autotransplantation
Tracheal stenosis (TS) is a complication of prolonged intubation, tracheotomy, and tracheal surgery that compromises the vascular supply. Animal models are essential for studying its pathophysiology and the effect of interventions. To establish a TS model in rats secondary to tracheal autotransplantation with a graft submerged in bleomycin (Atx-Bleo). Additionally, to evaluate the clinical and histological changes, as well as the expression of newly formed collagen (NFC), isoforms of transforming growth factor beta (TGFβ), fibronectin (FN), elastin (ELN), integrin β1 (ITGβ1), and matrix metalloproteinase 1 (MMP1) in TS. Twenty Wistar rats were divided into three groups: group I (n = 20) control; group II (n = 10) end-to-end anastomosis of the trachea (tracheoplasty); and group III (n = 10) Atx-Bleo. The animals were evaluated clinically, tomographically, macroscopically, morphometrically, and microscopically. NFC deposition, and the expression of profibrotic and antifibrotic proteins were evaluated in tracheal scars. All animals survived the surgical procedure and the study period. Compared with the other study groups, the Atx-Bleo group developed TS and fibrosis, exhibited higher expression of NFC, TGFβ1, TGFβ2, FN, ELN, and ITGβ1, and mild expression of TGFβ3 and MMP1 (p < 0.005; analysis of variance, Dunnett and Tukey tests). Atx-Bleo in TS model rats produces tomographic and histological changes, and induces the upregulation of profibrotic proteins (TGFβ1, TGFβ2, collagen, FN, ELN, ITGβ1) and downregulation of antifibrotic proteins (TGFβ3, MMP1). Therefore, this model may be used to test new pharmacological treatments for reversing or preventing TS, and conduct basic studies regarding its pathophysiology.
- 9 September 2020
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (1) , 191-200
Expression of Claudin-4 in Lung Ischemia-Reperfusion Injury in Experimental Lung Transplantation
During lung transplantation (LTx), the warm (WIT) and cold ischemia time (CIT) predispose to ischemia-reperfusion injury (LIRI) and the primary graft dysfunction (PGD). LIRI induces edema by changes in tight junctions (TJs) of pulmonary epithelial and endothelial cells. Claudin-4 (CLDN4) is a component of TJs that participates in edema resolution and has been used as an indicator of acute pulmonary damage.
- 9 September 2020
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (1) , 191-200
Expression of Claudin-4 in Lung Ischemia-Reperfusion Injury in Experimental Lung Transplantation
During lung transplantation (LTx), the warm (WIT) and cold ischemia time (CIT) predispose to ischemia-reperfusion injury (LIRI) and the primary graft dysfunction (PGD). LIRI induces edema by changes in tight junctions (TJs) of pulmonary epithelial and endothelial cells. Claudin-4 (CLDN4) is a component of TJs that participates in edema resolution and has been used as an indicator of acute pulmonary damage.